140 related articles for article (PubMed ID: 30358225)
1. Management and treatment of children with medulloblastoma in Serbia, a middle-income country.
Bokun J; Grujicic D; Skender-Gazibara M; Paripovic L; Pekmezovic T; Kisic-Tepavcevic D; Ilic V; Raicevic S; Stanic D; Miskovic I; Saric M; Nikitovic M
J BUON; 2018; 23(4):1156-1162. PubMed ID: 30358225
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
4. M1 Medulloblastoma: high risk at any age.
Sanders RP; Onar A; Boyett JM; Broniscer A; Morris EB; Qaddoumi I; Armstrong GT; Boop FA; Sanford RA; Kun LE; Merchant TE; Gajjar A
J Neurooncol; 2008 Dec; 90(3):351-5. PubMed ID: 18704266
[TBL] [Abstract][Full Text] [Related]
5. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital.
Walter AW; Mulhern RK; Gajjar A; Heideman RL; Reardon D; Sanford RA; Xiong X; Kun LE
J Clin Oncol; 1999 Dec; 17(12):3720-8. PubMed ID: 10577843
[TBL] [Abstract][Full Text] [Related]
6. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
7. [Pediatric medulloblastoma: Retrospective series of 52 patients].
Vigneron C; Antoni D; Coca A; Entz-Werlé N; Lutz P; Spiegel A; Jannier S; Niederst C; Jarnet D; Meyer P; Kehrli P; Noël G
Cancer Radiother; 2016 Apr; 20(2):104-8. PubMed ID: 26996790
[TBL] [Abstract][Full Text] [Related]
8. [Adult medulloblastoma: Retrospective series of 21 patients].
Vigneron C; Antoni D; Coca A; Niederst C; Jarnet D; Meyer P; Kehrli P; Noël G
Cancer Radiother; 2016 Feb; 20(1):14-7. PubMed ID: 26706607
[TBL] [Abstract][Full Text] [Related]
9. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcomes of medulloblastoma in adults.
Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
[TBL] [Abstract][Full Text] [Related]
11. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
12. [Medulloblastoma in children].
Hideghety K; Kerr C; Debrigode C; Dubois JB
Bull Cancer Radiother; 1994; 81(2):143-6. PubMed ID: 7702894
[No Abstract] [Full Text] [Related]
13. Current multimodality management of medulloblastoma.
Paulino AC
Curr Probl Cancer; 2002; 26(6):317-56. PubMed ID: 12447347
[No Abstract] [Full Text] [Related]
14. Medulloblastoma variants and survival at a children's hospital.
Craver R; Sandquist D; Nadell J; Velez M
Fetal Pediatr Pathol; 2011; 30(1):53-9. PubMed ID: 21204667
[TBL] [Abstract][Full Text] [Related]
15. Medulloblastoma in adults : A retrospective single institution analysis.
Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
[TBL] [Abstract][Full Text] [Related]
16. Management and outcomes of treating pediatric medulloblastoma: an eight years' experience in an Iranian pediatric center.
Mehrvar A; Tashvighi M; Hedayati Asl AA; Niktoreh-Mofrad N; Mehrvar N; Afsar N; Naderi A; Allebouyeh M; Qaddoumi I; Faranoush M
Childs Nerv Syst; 2018 Apr; 34(4):639-647. PubMed ID: 29214340
[TBL] [Abstract][Full Text] [Related]
17. Childhood medulloblastoma-a single institution's historical perspective on survival and functional morbidity.
Phipps K; Kirkman MA; Aquilina K; Gaze M; Michalski A; Wade A; Hayward R
Childs Nerv Syst; 2019 Dec; 35(12):2327-2338. PubMed ID: 31686139
[TBL] [Abstract][Full Text] [Related]
18. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
[TBL] [Abstract][Full Text] [Related]
19. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
Zeltzer PM; Boyett JM; Finlay JL; Albright AL; Rorke LB; Milstein JM; Allen JC; Stevens KR; Stanley P; Li H; Wisoff JH; Geyer JR; McGuire-Cullen P; Stehbens JA; Shurin SB; Packer RJ
J Clin Oncol; 1999 Mar; 17(3):832-45. PubMed ID: 10071274
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastoma: a critical approach to the management on the basis of 12 years of experience.
Colangelo M; Daniele B; Ruggiero R; Buonaguro A; Ambrosio A
Childs Nerv Syst; 1987; 3(2):81-4. PubMed ID: 3621232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]